Exploratory study on continuation of COVID-19 Vaccination Programme RIVM has commissioned ABDTOPconsult to do an independent exploratory study on systematic approaches to organising and incorporating the current RIVM COVID-19 Vaccination Programme.
Early indicators added to coronavirus monitoring in sewage on Coronavirus Dashboard This week, early indicators were added to the sewage measurements page on the Coronavirus Dashboard provided by the national government. These values help to clarify the measurements by indicating how serious the situation is.
Delta variant on the rise The delta variant of the coronavirus SARS-CoV-2 is occurring more and more often in the Netherlands.
COVID-19 vaccination very effective: major drop in positive tests, hospital admissions and deaths among older people People over 75 years old living at home are 82% protected against testing positive for COVID-19 from three weeks after the second vaccination.
Launch of the European project RISK-HUNT3R The new Horizon 2020 project RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs was launched on 1 June.
Effects of COVID-19 vaccination becoming increasingly visible In the past calendar week, there were 43% fewer hospital admissions of patients with COVID-19 compared to the week before.
Largest drop in number of tuberculosis cases in the Netherlands in fifty years Last year, the incidence of tuberculosis (TB) in the Netherlands fell sharply. The 17% drop is the largest in fifty years. In 2020, 623 cases were notified compared to 754 in 2019.
Method for safe and sustainable recycling of waste The method developed by RIVM to assess whether waste treatment is sufficiently safe and sustainable, can contribute to the European ambitions for a safe and more circular economy.
Vaccination with AstraZeneca vaccine will start again The Ministry of Health, Welfare and Sport (VWS) has decided to resume vaccinating with the COVID-19 vaccine made by AstraZeneca within the near future.
First invitations for people aged 75-79 years arriving Saturday Starting tomorrow, the first people in the age group from 75-79 years will receive an invitation from RIVM for a COVID-19 vaccination. These people were born in the years from 1941 through 1946.